Atlas Trials

A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy

Clinical trial NCT00998166 · TERMINATED

Trial details

NCT number
NCT00998166
Sponsor
Columbia University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2009-06-01
Primary completion
2011-10-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.